A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2018
At a glance
- Drugs KBP 042 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors KeyBioScience
- 04 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Oct 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2017 New trial record